The trademark application MITYTRAV was filed by Bristol-Myers Squibb Company, a U.S. corporation (the "Applicant"). The application was published for oppositions on March 3, 2021, and it was registered by office on June 10, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024.